RETAKLIK 2.0 (RETATRUTIDE + CAGRILINTIDE) 30+5mg
Product code CLV-RETACAG-35
£202.50
RETAKLIK 2.0 combines Retatrutide 30mg and Cagrilintide 5mg in one pen.
- No report published yet for this product
- Delivery options and charges
- Compare with another product
RETAKLIK 2.0 is a combined formulation: Retatrutide, a GIP/GLP-1/glucagon receptor agonist, with Cagrilintide, a long-acting analogue of the hormone amylin, in a single pen.
Composition and strength
Retatrutide 30mg + Cagrilintide 5mg, as listed. This is a different item from the 45mg (40mg + 5mg) Retatrutide & Cagrilintide listing and from the two-pen Reta + Cag bundle.
Format
One pre-filled pen in a RETAKLIK 2.0 carton.
Storage
Store refrigerated at 2–8°C. Do not freeze. Keep in the original carton, away from light.
Supplied for laboratory research use only. Not for human or veterinary use.
| Product code | CLV-RETACAG-35 |
|---|---|
| Strength | — |
| Brand | APEX Pharma |
| Label name | RETAKLIK 2.0 |
| Active ingredients | Retatrutide + Cagrilintide |
| Labelled strength | 30mg + 5mg |
| Pack | 1 pre-filled pen |
| Storage | 2–8°C, do not freeze, protect from light |
| Intended use | Laboratory research only |
Composition
Retatrutide 30mg + Cagrilintide 5mg
Storage
Store refrigerated at 2–8°C. Do not freeze. Keep in the original carton, away from light.
No Certificate of Analysis has been published for this product yet. Email our team to ask about documentation for current stock.
Packed cold in insulated, discreet and unbranded outer packaging, and sent by tracked delivery.
Orders paid before 1pm (UK time), Monday to Friday, are dispatched the same working day. Orders paid later, or at weekends and on UK bank holidays, are dispatched the next working day.
- UK Standard: £4.99, free over £100.00. 2–4 working days after dispatch
- UK Tracked Next Working Day: £9.99. Next working day when paid before 1pm (UK time), Monday to Friday
Is a Certificate of Analysis available for this product?
No reviews published yet.
Write a reviewRETAKLIK 2.0 — Retatrutide + Cagrilintide product information
RETAKLIK 2.0 combines Retatrutide (30mg) and Cagrilintide (5mg) in one labelled pen. Cagrilintide is a long-acting amylin analogue studied in research settings; neither compound is a licensed medicine in the UK. This page lists the labelled amounts, packaging details, UK price and stock, and batch documentation where published.
No Certificate of Analysis has been published for this product yet. Email our team to ask about documentation for current stock. See the storage guide for storage and handling on arrival. Single-compound listings: Retatrutide 40mg and KLIKTIDE Cagrilintide 10mg. Supplied for laboratory research use only; not for human or animal use.
